Drug Information

Drug General Information
Drug ID
D0L8ZX
Former ID
DIB002094
Drug Name
OX-NLA
Synonyms
NLA; BLX-NLA; NCX-1510; NO-donating therapeutics, Biolipox; Anti-allergy drug, NicOx/Biolipox; NO-donating allergy therapeutics, Biolipox/Nicox; NO-donating respiratory therapeutics, NicOx/Biolipox; NO-donating therapeutics, Biolipox/Nicox; Liposomal nitric oxide-donating cetirizine derivative (nasal, rhinitis), Biolipox; Nitric oxide-donating cetirizine derivative (liposomal, intranasal, rhinitis), Orexo; OX-NLA (nasal/liposomal formulation, allergic rhinitis/rhinitis); OX-NLA (nasal/liposomal formulation, allergic rhinitis/rhinitis), Meda
Drug Type
Small molecular drug
Indication Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] Discontinued in Phase 3 [547891]
Company
NicOx SA
Structure
Download
2D MOL

3D MOL
Formula
C12H10O2
Canonical SMILES
C1=CC=C2C(=C1)C=CC=C2CC(=O)O
InChI
1S/C12H10O2/c13-12(14)8-10-6-3-5-9-4-1-2-7-11(9)10/h1-7H,8H2,(H,13,14)
InChIKey
PRPINYUDVPFIRX-UHFFFAOYSA-N
PubChem Compound ID
6862
PubChem Substance ID
79563, 583403, 607070, 841137, 3134013, 5432030, 7848621, 7889419, 8145294, 8154475, 10537141, 14843290, 17389810, 24698070, 24859106, 24861915, 24897435, 24897513, 26752862, 29225802, 46392458, 46508218, 48130882, 48414086, 48424424, 49748196, 49825821, 49835454, 49857515, 56310850, 56311443, 56312339, 56312506, 56312529, 56370060, 57288437, 57323764, 57649420, 77411102, 85088003, 87573419, 88575942, 92117615, 92711073, 102851767, 103101651, 103173439, 103932809, 104313279, 104652675
Target and Pathway
Target(s) Histamine receptor Target Info Antagonist [551474]
References
Ref 547891Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020184)
Ref 551474Clinical pipeline report, company report or official report of Orexo.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.